Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study

Vitreoretinal Interface Changes After Anti-vascular Endothelial Growth Factor Treatment in Highly Myopic Eyes: A Real-World Study

Abstract Introduction To investigate changes in the vitreoretinal interface after anti-vascular endothelial growth factor (anti-VEGF) treatment in highly myopic eyes. Methods Eyes with myopic choroidal neovascularization (mCNV) treated with intravitreal injection of anti-VEGF in a single-center were...

Full description

Bibliographic Details
Main Authors: Mei-Chi Tsui, Yi-Ting Hsieh, Tso-Ting Lai, Yun Hsia, Shih-Wen Wang, I-Hsin Ma, Kuo-Chi Hung, Chang-Pin Lin, Chang-Hao Yang, Chung-May Yang, Tzyy-Chang Ho
Format: Article
Language:English
Published: Adis, Springer Healthcare 2023-04-01
Series:Ophthalmology and Therapy
Subjects:
Anti-vascular endothelial growth factor
High myopia
Myopic choroidal neovascularization
Myopic macular retinoschisis
Myopic traction maculopathy
Vitreoretinal interface
Online Access:https://doi.org/10.1007/s40123-023-00701-4

Internet

https://doi.org/10.1007/s40123-023-00701-4

Similar Items